← SynDRA
MOEXIPRIL
SynDRA canonical compound SYN0004210 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ACE |
|---|
| Mechanism of action | Angiotensin converting enzyme inhibitor |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- SLC33A1 INHIBITOR
- SLC33A1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ADORA3
- TBXA2R
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- KCNH2
- HTR2B
- HTR1A
- HRH3
- HDAC6
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADRA1A
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Angiotensin-converting Enzyme Inhibitors
- Angiotensin Converting Enzyme Inhibitor
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protease Inhibitors
ATC classes
- C09A · ACE INHIBITORS, PLAIN
- ACE INHIBITORS, COMBINATIONS
Cross-references
Synonyms
- MOEXIPRIL HYDROCHLORIDE
- MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
- UNIRETIC
- UNIVASC
- moexipril hydrochloride
- moclobenid
- moexipril HCl
- Uniretic
- RS-10085
- Moexiprilum
- Moexipril (INN)
- Moexipril [INN:BAN]
- Moexiprilum [INN-Latin]
- Perdix (TN)
- Univasc (TN)
- WT87C52TJZ
- Moex
- RefChem:819096
- DTXCID803330
- C09AA13
- MOEXIPRIL [INN]
- UNII-WT87C52TJZ
- MOEXIPRIL [MI]
- MOEXIPRIL [VANDF]
- MOEXIPRIL [WHO-DD]
- SCHEMBL34030
- BIDD:GT0007
- CHEBI:6960
- GTPL6571
- orb1686666
- SCHEMBL29376544
- UWWDHYUMIORJTA-HSQYWUDLSA-N
- BDBM50084673
- EBC-27236
- EX-A12329
- AKOS015843317
- NCGC00263546-03
- HY-117281
Reported adverse events
- Angioedema
- Cough
- Dizziness
- Fatigue
- Flushing
- Myalgia
- Pharyngitis
- Rash
- Abdominal pain
- Bronchospasm
Look up MOEXIPRIL in the interactive SynDRA portal →